What is the issue price of Sai Life Sciences IPO?

Sai Life Sciences IPO issue price band is ₹522-549 per share with a lot size of 23 Shares.

When is Sai Life Sciences IPO listing date?

Sai Life Sciences IPO listed on Dec 18, 2024 at ₹585.

Sai Life Sciences IPO GMP Today Live ₹30 | Allotment Status & Subscription

Q: How to check Sai Life Sciences IPO allotment status?

You can check Sai Life Sciences IPO allotment status on the registrar (KFin Technologies) website using your PAN or application number.

Q: What is Sai Life Sciences IPO subscription status?

Sai Life Sciences IPO subscription: QIB 8.6x, NII 3.4x, Retail 1.8x.

Live Grey Market Premium+₹30

Expected Listing₹579

Expected Gain+5.46%

Subscription Status

QIB8.6x

NII / HNI3.4x

Retail1.8x

Listing Performance

Issue Price₹522-549

Listing Price₹585

Sai Life Sciences: Detailed Financial Analysis

## Sai Life Sciences IPO: Comprehensive Financial Analysis Sai Life Sciences launched its Initial Public Offering (IPO) with a total issue size of ₹3,043 Cr, offering shares in the price band of ₹522-549 per share with a minimum lot size of 23 Shares. The IPO opened for subscription on Dec 11, 2024 and closed on Dec 13, 2024. The stock listed at ₹585 against an issue price of ₹522-549, delivering significant listing gains to investors. ### Grey Market Premium (GMP) Analysis The current Grey Market Premium (GMP) for Sai Life Sciences stands at ₹30 per share, indicating positive market sentiment and strong demand in the unofficial grey market. A positive GMP suggests that investors expect the stock to list above its issue price, which is a bullish indicator for potential listing gains. ### Subscription Status The institutional response to Sai Life Sciences IPO has been noteworthy. The Qualified Institutional Buyers (QIB) category was subscribed 8.6x. Non-Institutional Investors (NII) showed 3.4x subscription, while the Retail Individual Investor (RII) category recorded 1.8x subscription. ### Investment Considerations Investors evaluating Sai Life Sciences should consider several key factors. The company operates in a dynamic market segment with strong revenue growth trajectory and improving profit margins. The issue price valuation at ₹522-549 per share positions the company at a reasonable valuation compared to listed industry peers. Key risk factors include market volatility, regulatory changes, and sector-specific headwinds that could impact post-listing performance. Investors should carefully review the Draft Red Herring Prospectus (DRHP) filed with SEBI for complete financial disclosures, including revenue trends, profitability metrics, debt-to-equity ratios, and management discussion on future growth strategies. ### Allotment and Listing Timeline The allotment for Sai Life Sciences IPO has been finalized. Investors can check their allotment status through the registrar KFin Technologies's website. The stock is now listed and trading on BSE and NSE. ### Market Outlook Given the strong subscription numbers and positive GMP, Sai Life Sciences appears well-positioned for a favorable listing. The robust institutional demand particularly from QIBs validates the company's business model and growth prospects. However, investors should maintain realistic return expectations and consider holding for medium to long-term value creation rather than purely speculative listing gains. *Disclaimer: Grey Market Premium data is sourced from unofficial market channels and should not be considered investment advice. Past GMP trends do not guarantee future listing performance. Investors should conduct their own due diligence and consult SEBI-registered investment advisors before making investment decisions.*

Frequently Asked Questions

What is Sai Life Sciences IPO GMP today?▼

The current Grey Market Premium for Sai Life Sciences IPO is ₹30. This positive GMP indicates strong market demand.

How to check Sai Life Sciences IPO allotment status?▼

Visit the registrar (KFin Technologies) website and enter your PAN or application number. You can also check on BSE's allotment status page.

What is Sai Life Sciences IPO subscription status?▼

QIB category: 8.6x, NII/HNI category: 3.4x, Retail category: 1.8x.

Should I invest in Sai Life Sciences IPO?▼

Investment decisions should be based on thorough research of the company's financials, growth prospects, and risk factors outlined in the DRHP. Consult a SEBI-registered advisor.

What is the lot size and price band of Sai Life Sciences IPO?▼

The minimum lot size is 23 Shares with a price band of ₹522-549. Total minimum investment required is approximately the lot size multiplied by the upper price band.

Sai Life Sciences IPO

Subscription Status

Listing Performance

Check Sai Life Sciences Allotment Status

Sai Life Sciences: Detailed Financial Analysis

Frequently Asked Questions

Related 2024 IPOs

Tata Technologies

IREDA

Cello World

Mama Earth (Honasa Consumer)

JSW Infrastructure

Mankind Pharma